Form 4 for BNTC Benitec Biopharma Inc.

Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-18 · accession 0000899140-25-001459 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2025-12-22	2025-12-18+	BNTC	Averill Madison Master Fund, Ltd.	10%	P - Purchase	$11.68	+46.1K	1.83M	+3%	+$539.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $0.0001 per share	2025-12-18	P	A	8,700	$11.24	9,546,875	I See footnotes	—	—	(F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
2	Common	Common stock, par value $0.0001 per share	2025-12-22	P	A	16,650	$12.08	9,577,475	I See footnotes	—	—	(F6) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
3	Common	Common stock, par value $0.0001 per share	2025-12-19	P	A	2,434	$11.48	1,823,761	I See footnotes	—	—	(F5) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
4	Common	Common stock, par value $0.0001 per share	2025-12-19	P	A	13,950	$11.48	9,560,825	I See footnotes	—	—	(F4) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
5	Common	Common stock, par value $0.0001 per share	2025-12-18	P	A	1,515	$11.24	1,821,327	I See footnotes	—	—	(F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
6	Common	Common stock, par value $0.0001 per share	2025-12-22	P	A	2,892	$12.08	1,826,653	I See footnotes	—	—	(F7) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.